Last reviewed · How we verify

NCT03268486

Evaluation of a Novel Signal Acquisition Technique for Intrapartum Cardiotocography

Status unknown Last updated 31 August 2017
What this trial tests

trial in Labor Fetal Anoxia in 50 participants. Status unknown.

Timeline
1 October 2017
Primary endpoint
1 May 2018
31 May 2019

Quick facts

Lead sponsorUniversity of Lisbon
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment50
Start date1 October 2017
Primary completion1 May 2018
Estimated completion31 May 2019

Conditions studied

Sponsor

University of Lisbon

Who can join

18 and older, female only, with Labor Fetal Anoxia or Fetal Monitoring. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Cardiotocography (CTG) is widely used during labour wards in industrialised countries and consists of fetal heart rate and uterine contraction monitoring. The main aim is to identify fetuses that are being poorly oxygenated during labour and require medical intervention to revert the situation or expedite delivery. The need for technical development of CTG is well-recognized, as some of the existing techniques are prone to signal loss and contamination from the maternal heart rate, while others are invasive and have established contra-indications. They also limit maternal mobilisation, contributing to maternal dissatisfaction, and possibly to adverse maternal and neonatal outcomes. New techniques for CTG acquisition will shortly be made available by a leading technological company, providing non-invasive monitoring and allowing full maternal mobilisation, and with the potential to change the way labour is conducted in high-resource countries. There is a need for a systematic evaluation of their clinical performance and benefit.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other University of Lisbon trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03268486.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing